Response to: Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.

Johan Karlsson Wallman; Elisabeth Mogard; Jan Marsal; Kristofer Andréasson; Anna Jöud; Mats Geijer; Lars Erik Kristensen; Elisabet Lindqvist; Tor Olofsson

doi:10.1136/annrheumdis-2019-216752

Response to: Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.

Johan Karlsson Wallman, Elisabeth Mogard, Jan Marsal, Kristofer Andréasson, Anna Jöud, Mats Geijer, Lars Erik Kristensen, Elisabet Lindqvist, Tor Olofsson

Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial

Originalspråk	engelska
Artikelnummer	216752
Sidor (från-till)	e10-e10
Tidskrift	Annals of the Rheumatic Diseases
Volym	81
Nummer	1
Tidigt onlinedatum	2019 dec. 31
DOI	https://doi.org/10.1136/annrheumdis-2019-216752
Status	Published - 2022

Ämnesklassifikation (UKÄ)

Reumatologi och inflammation

Tillgång till dokument

10.1136/annrheumdis-2019-216752

Andra filer och länkar

Link to publication in Scopus

Citera det här

Wallman, J. K., Mogard, E., Marsal, J., Andréasson, K., Jöud, A., Geijer, M., Kristensen, L. E., Lindqvist, E., & Olofsson, T. (2022). Response to: Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al. Annals of the Rheumatic Diseases, 81(1), e10-e10. Artikel 216752. https://doi.org/10.1136/annrheumdis-2019-216752

@article{9bed6ed02f9a44b3a8dcbbf5f8fc56ad,

title = "Response to: Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.",

keywords = "ankylosing spondylitis, epidemiology, fibromyalgis/pain syndromes, NSAIDs, spondyloarthritis",

author = "Wallman, {Johan Karlsson} and Elisabeth Mogard and Jan Marsal and Kristofer Andr{\'e}asson and Anna J{\"o}ud and Mats Geijer and Kristensen, {Lars Erik} and Elisabet Lindqvist and Tor Olofsson",

year = "2022",

doi = "10.1136/annrheumdis-2019-216752",

language = "English",

volume = "81",

pages = "e10--e10",

journal = "Annals of the Rheumatic Diseases",

issn = "0003-4967",

publisher = "BMJ Publishing Group",

number = "1",

}

Wallman, JK , Mogard, E, Marsal, J, Andréasson, K , Jöud, A , Geijer, M, Kristensen, LE, Lindqvist, E & Olofsson, T 2022, 'Response to: Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.', Annals of the Rheumatic Diseases, vol. 81, nr. 1, 216752, s. e10-e10. https://doi.org/10.1136/annrheumdis-2019-216752

Response to: Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al. / Wallman, Johan Karlsson ; Mogard, Elisabeth; Marsal, Jan et al.
I: Annals of the Rheumatic Diseases, Vol. 81, Nr. 1, 216752, 2022, s. e10-e10.

Forskningsoutput: Tidskriftsbidrag › Debate/Note/Editorial

TY - JOUR

T1 - Response to

T2 - Response to: Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: Is it an overlooked comorbidity?' by Proft et al.

AU - Wallman, Johan Karlsson

AU - Mogard, Elisabeth

AU - Marsal, Jan

AU - Andréasson, Kristofer

AU - Jöud, Anna

AU - Geijer, Mats

AU - Kristensen, Lars Erik

AU - Lindqvist, Elisabet

AU - Olofsson, Tor

PY - 2022

Y1 - 2022

KW - ankylosing spondylitis

KW - epidemiology

KW - fibromyalgis/pain syndromes

KW - NSAIDs

KW - spondyloarthritis

UR - http://www.scopus.com/inward/record.url?scp=85077436691&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2019-216752

DO - 10.1136/annrheumdis-2019-216752

M3 - Debate/Note/Editorial

C2 - 31892532

AN - SCOPUS:85077436691

SN - 0003-4967

VL - 81

SP - e10-e10

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

IS - 1

M1 - 216752

ER -